Omega-3 Icosapent Ethyl and Stroke Reduction in Atherosclerotic Vascular Disease

This timely symposium highlights Cardiovascular Outcomes Trials of Omega-3 Fatty Acids in ASCVD. The focus is on the hottest topics on practical considerations to manage patients post-MI and post-stroke and at high risk of further cardiovascular disease.

[Okraknife]

Using icosapent ethyl, I went from having dangerously high triglyceride levels to less than 150.